| Dr Sankalp Pathak, MD | |
|
59-61 High Street, Newton, NJ 07860 | |
| (973) 300-1302 | |
| (973) 300-1201 |
| Full Name | Dr Sankalp Pathak |
|---|---|
| Gender | Male |
| Speciality | Interventional Cardiology |
| Experience | 13 Years |
| Location | 59-61 High Street, Newton, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1316388234 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0011X | Internal Medicine - Interventional Cardiology | 25MA10159100 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Newton Medical Center | Newton, NJ | Hospital |
| Saint Barnabas Medical Center | Livingston, NJ | Hospital |
| Morristown Medical Center | Morristown, NJ | Hospital |
| Hackettstown Medical Center | Hackettstown, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Advanced Cardiology Llc | 5597751735 | 20 |
News Archive
One of the main limiting factors for a traditional x-ray source is the thermal management of the solid fixed, or rotating, anode leading to overheating or even melting as the electron beam power is increased.
Researchers know that certain factors give children a leg up when it comes to school performance. Family income, access to early childhood programs and home environment rank high on the list.
Promedior, Inc., today announced positive preliminary data from its Phase 2 trial of PRM-151, an anti-fibrotic immunotherapy, in patients with myelofibrosis which demonstrated biologic activity with improvements across clinically relevant measures, including bone marrow fibrosis, hemoglobin, platelets, spleen, and symptoms.
MacroGenics, Inc., a privately held biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases, today announced the publication in the journal Blood of preclinical data demonstrating potent inhibition of B-cell lymphoma through redirected T lymphocyte-mediated killing, using its bispecific DART antibody technology.
› Verified 5 days ago
| Entity Name | Cardiovascular Health Consultants, P.a. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437291739 PECOS PAC ID: 8325934706 Enrollment ID: O20040224000028 |
News Archive
One of the main limiting factors for a traditional x-ray source is the thermal management of the solid fixed, or rotating, anode leading to overheating or even melting as the electron beam power is increased.
Researchers know that certain factors give children a leg up when it comes to school performance. Family income, access to early childhood programs and home environment rank high on the list.
Promedior, Inc., today announced positive preliminary data from its Phase 2 trial of PRM-151, an anti-fibrotic immunotherapy, in patients with myelofibrosis which demonstrated biologic activity with improvements across clinically relevant measures, including bone marrow fibrosis, hemoglobin, platelets, spleen, and symptoms.
MacroGenics, Inc., a privately held biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases, today announced the publication in the journal Blood of preclinical data demonstrating potent inhibition of B-cell lymphoma through redirected T lymphocyte-mediated killing, using its bispecific DART antibody technology.
› Verified 5 days ago
| Entity Name | Garden State Cardiovascular Specialists Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225059660 PECOS PAC ID: 8527053511 Enrollment ID: O20040419000924 |
News Archive
One of the main limiting factors for a traditional x-ray source is the thermal management of the solid fixed, or rotating, anode leading to overheating or even melting as the electron beam power is increased.
Researchers know that certain factors give children a leg up when it comes to school performance. Family income, access to early childhood programs and home environment rank high on the list.
Promedior, Inc., today announced positive preliminary data from its Phase 2 trial of PRM-151, an anti-fibrotic immunotherapy, in patients with myelofibrosis which demonstrated biologic activity with improvements across clinically relevant measures, including bone marrow fibrosis, hemoglobin, platelets, spleen, and symptoms.
MacroGenics, Inc., a privately held biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases, today announced the publication in the journal Blood of preclinical data demonstrating potent inhibition of B-cell lymphoma through redirected T lymphocyte-mediated killing, using its bispecific DART antibody technology.
› Verified 5 days ago
| Entity Name | Advanced Cardiology Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295871796 PECOS PAC ID: 5597751735 Enrollment ID: O20040422000915 |
News Archive
One of the main limiting factors for a traditional x-ray source is the thermal management of the solid fixed, or rotating, anode leading to overheating or even melting as the electron beam power is increased.
Researchers know that certain factors give children a leg up when it comes to school performance. Family income, access to early childhood programs and home environment rank high on the list.
Promedior, Inc., today announced positive preliminary data from its Phase 2 trial of PRM-151, an anti-fibrotic immunotherapy, in patients with myelofibrosis which demonstrated biologic activity with improvements across clinically relevant measures, including bone marrow fibrosis, hemoglobin, platelets, spleen, and symptoms.
MacroGenics, Inc., a privately held biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases, today announced the publication in the journal Blood of preclinical data demonstrating potent inhibition of B-cell lymphoma through redirected T lymphocyte-mediated killing, using its bispecific DART antibody technology.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sankalp Pathak, MD 65 Ridgedale Ave, Cedar Knolls, NJ 07927-1313 Ph: (973) 401-1100 | Dr Sankalp Pathak, MD 59-61 High Street, Newton, NJ 07860 Ph: (973) 300-1302 |
News Archive
One of the main limiting factors for a traditional x-ray source is the thermal management of the solid fixed, or rotating, anode leading to overheating or even melting as the electron beam power is increased.
Researchers know that certain factors give children a leg up when it comes to school performance. Family income, access to early childhood programs and home environment rank high on the list.
Promedior, Inc., today announced positive preliminary data from its Phase 2 trial of PRM-151, an anti-fibrotic immunotherapy, in patients with myelofibrosis which demonstrated biologic activity with improvements across clinically relevant measures, including bone marrow fibrosis, hemoglobin, platelets, spleen, and symptoms.
MacroGenics, Inc., a privately held biotechnology company that develops immunotherapeutics to treat autoimmune disorders, cancer and infectious diseases, today announced the publication in the journal Blood of preclinical data demonstrating potent inhibition of B-cell lymphoma through redirected T lymphocyte-mediated killing, using its bispecific DART antibody technology.
› Verified 5 days ago
Aradhana Aggarwal, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 175 High St, Newton, NJ 07860 Phone: 973-383-2121 | |
Dr. Hristo Vassilev Stoytchev, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 175 High St, Newton, NJ 07860 Phone: 973-383-2121 Fax: 973-898-3905 | |
Vandankumar Patel, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 175 High St, Newton, NJ 07860 Phone: 973-383-2121 Fax: 973-383-8973 | |
Dr. Daya Nadarajah, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 222 High St, Suite 102, Newton, NJ 07860 Phone: 973-579-5090 Fax: 973-579-7409 | |
Dr. Samir Dilip Shah, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 123 Newton Sparta Rd, Newton, NJ 07860 Phone: 973-579-6300 Fax: 973-579-1524 | |
Dr. Nick Paul Debitetto, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 123 Newton Sparta Rd, Newton, NJ 07860 Phone: 973-579-6300 Fax: 973-579-1524 | |
Dr. Gerald Cioce, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 222 High St, Suite 205, Newton, NJ 07860 Phone: 973-579-2100 Fax: 973-579-6638 |